We tend to think of age as a linear progression marked by birthdays and milestones dictating when we can vote, drink, rent a car or pass beyond the crest of an arbitrary metaphorical hill. When scientists look at how organs ...
19 minutes ago
0
0
The interleukin-6 (IL-6) antibody pacibekitug produced sustained reductions in inflammatory biomarkers in patients with chronic kidney disease at high inflammatory risk, according to results from the Phase II TRANQUILITY ...
19 minutes ago
0
0
Edoxaban did not reduce stroke or systemic embolism but increased major bleeding in high-risk patients with atrial fibrillation who had had an intracranial hemorrhage, according to results presented in a Hot Line session ...
39 minutes ago
0
0
Why do some joints remain chronically inflamed in osteoarthritis and other rheumatic diseases? Researchers have taken an important step toward answering this question. Their findings, published in the journal Cell Death & ...
39 minutes ago
0
0
Immediate initiation of evolocumab after a heart attack significantly improved low-density lipoprotein cholesterol (LDL-C) goal achievement, but an early reduction in all-cause death or unplanned cardiovascular hospitalization ...
59 minutes ago
0
0
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their constituent cells. Such ...
59 minutes ago
0
0
Early ECG monitoring initiated in the emergency department (ED) has the potential to transform the care of thousands of patients who visit the ED with unexplained fainting.
1 hour ago
0
0
More than 40% of American women ages 40 and older have dense breast tissue, according to the National Cancer Institute. This type of tissue can make cancer harder to spot on mammograms and is itself associated with a higher ...
1 hour ago
0
0
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease ...
1 hour ago
0
0
Metformin did not significantly affect the risk of cardiovascular outcomes in patients with heart failure with reduced ejection fraction and diabetes or at risk of diabetes. These were the main findings of the Met-HeFT trial ...
1 hour ago
0
0
